| |
Adimab
Avedro
Bar Harbor Biotechnology
GlycoFi
M2S |
Avedro, Inc. is a development-stage medical device company with patented technology developed at Dartmouth College for a new, non-incisional means of refractive surgery. |
 Avedro, Inc.
230 3rd Avenued
Waltham, MA 02451
Initial Investment: January 2003
CEO: David Muller Ph.D. |
|